Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tiaprid (ATC-Code:N05AL03).
AOK Niedersachsen. Die Gesundheitskasse.
The work
Conclusion of a non-exclusive discount contract for the active substance Tiaprid (ATC-Code:N05AL03) via an 'open-house model' from 01.02.2026 to 31.01.2028.
- Contract must be for Tiaprid (ATC-Code:N05AL03).
- Must be a non-exclusive discount contract under § 130a Abs. 8 SGB V.
- Must be concluded with a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined by § 4 Abs. 18 AMG.
Key facts
- Contract period
- Up to 24 months, ending by 31.01.2028.
- Evaluation
- Not a public procurement; selection is based on meeting the legal definition of a pharmaceutical entrepreneur.
What it takes to qualify
Worth a closer look
- The tender is not a public procurement in the sense of Directive 2014/24/EU.
- The publication is for transparency and uses the 'offenes Verfahren' terminology due to the publication form.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
- Being a pharmaceutical entrepreneur with a seat in the AMG area, EU, or EEA.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not mentioned in the provided text.
PAN registration (optional)Not mentioned in the provided text.
EPF registration (optional)Not mentioned in the provided text.
ESIC registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documents and conditionsTo be requested from AOK Niedersachsen and submitted.